NCT02820896 A Study of RO7105705 in Healthy Participants and Participants With Mild-to-Moderate Alzheimer's Disease Status COMPLETED Phase PHASE1
NCT02814045 Role of Hypoxia Ans Sleep Fragmentation in Alzheimer's Disease. and Sleep Fragmentation. Status COMPLETED Phase N/A
NCT02813070 Comparison of PET Amyloid Imaging in Japanese and Western Subjects Status COMPLETED Phase PHASE2
NCT02795780 Follow up 18F-AV-1451 Scan in Confirmatory Cohort Subjects From Study 18F-AV-1451-A05 Status COMPLETED Phase PHASE2
NCT02792257 Trial of Dronabinol Adjunctive Treatment of Agitation in Alzheimer's Disease Status COMPLETED Phase PHASE2
NCT02792179 Evaluation of [18F]RO6958948 as Tracer for Positron Emission Tomography (PET) Imaging of Tau Burden in Alzheimer's Disease Participants Status COMPLETED Phase PHASE1
NCT02791191 A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia Status TERMINATED Phase PHASE2
NCT02789800 Patient-Centred Innovations for Persons With Multimorbidity - Quebec Status COMPLETED Phase NA
NCT02787746 Safety and Efficacy of Donepezil in Mild to Moderate Alzheimer's Disease Status COMPLETED Phase PHASE4
NCT02783573 A Study of Lanabecestat (LY3314814) in Participants With Mild Alzheimer's Disease Dementia Status TERMINATED Phase PHASE3
NCT02782975 Absolute Bioavailability of a Single, Fixed Subcutaneous Dose of Aducanumab in Healthy Participants Status COMPLETED Phase PHASE1
NCT02781220 Implications for Management of PET Amyloid Classification Technology in the Imaging Dementia(IDEAS) Trial Status TERMINATED Phase N/A
NCT02778971 Implications for Management of PET Amyloid Classification Technology Status COMPLETED Phase N/A
NCT02778438 A Validation Study of the Novel Application of Telehealth in Clinical Drug Development in Subjects With Mild Cognitive Deficits Status COMPLETED Phase N/A
NCT02772523 Control and Intervention Programme on Alzheimer's Disease Risk Factors Status COMPLETED Phase NA
NCT02772185 Neurostimulation and Cognitive Intervention in Alzheimer's Disease Status UNKNOWN Phase PHASE2/PHASE3
NCT02769000 Low Dose RT to Reduce Cerebral Amyloidosis in Early Alzheimer's Status TERMINATED Phase NA
NCT02767609 Measuring Cerebral Blood Flow Using Pseudo-continuous Arterial Spin Labeling Perfusion Magnetic Resonance Imaging Status COMPLETED Phase NA